Catalyst Wire Dossier Catalyst Wire Dossier

KORTUC

· Institute of Cancer Research
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KORTUC, covering 2020-11-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer [Phase 2]

See pricing